D-1274-2020 Class II Terminated
FDA drug recall D-1274-2020 was initiated by West-Ward Columbus Inc on May 13, 2020 and is designated Class II. Reason for recall: Failed dissolution specification: The dissolution test at the 24 month time point (end of shelf life) yielded an out of specification result. The recall status is terminated (terminated Mar 25, 2023). Affected quantity: 68,376 bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Jun 3, 2020
- Initiation Date
- May 13, 2020
- Termination Date
- Mar 25, 2023
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 68,376 bottles
Product description
Doxycycline Hyclate Tablets USP, 100 mg, packaged in a) 50-count bottle (NDC 0143-2112-50), b) 500-count bottle (NDC 0143-2112-05), Rx only, Mfd. by: West-Ward Pharmaceuticals Corp., Eatontown, NJ 07724.
Reason for recall
Failed dissolution specification: The dissolution test at the 24 month time point (end of shelf life) yielded an out of specification result.
Distribution pattern
USA Nationwide
Code information
Lot #: a) 71846B, Exp 6/2021; b) 71726A, Exp 6/2020; 71846B, 71853A, Exp 6/2021
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-1274-2020
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026